Gilead Sciences (GILD) Change in Taxes (2009 - 2026)

Gilead Sciences (GILD) posted Change in Taxes of -$29.0 million for Q1 2026, up 78.36% quarter-over-quarter from -$134.0 million in Q4 2025, and up 94.75% year-on-year from -$14.9 million in Q1 2025.

Gilead Sciences (GILD) Change in Taxes (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Change in Taxes for 18 consecutive years, with -$29.0 million the latest figure, recorded in Q1 2026.

  • Change in Taxes for Q1 2026 came in at -$29.0 million, up 94.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.6 billion (down 47.3% YoY), and the FY2025 annual result was -$2.1 billion, down 187.98% from the prior year.
  • Change in Taxes was -$29.0 million for Q1 2026 at Gilead Sciences, up from -$134.0 million in the prior quarter.
  • Over five years, Change in Taxes peaked at $536.0 million in Q4 2024 and troughed at -$1.3 billion in Q2 2025.
  • Average Change in Taxes over 5 years is -$294.2 million, with a median of -$134.0 million recorded in 2025.
  • The widest YoY moves for Change in Taxes: up 176.79% in 2024, down 4082.14% in 2024.
  • Over 5 years, Change in Taxes stood at $119.0 million in 2022, then sank by 686.55% to -$698.0 million in 2023, then soared by 176.79% to $536.0 million in 2024, then slumped by 125.0% to -$134.0 million in 2025, then jumped by 78.36% to -$29.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Taxes figures were -$29.0 million in Q1 2026, -$134.0 million in Q4 2025, and -$122.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -81.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -526.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 71.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -29.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 18.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.00 Mn
Mar 31, 2026 -29.00 Mn
Dec 31, 2025 -134.00 Mn
Dec 31, 2025 -134.00 Mn
Sep 30, 2025 -122.00 Mn
Sep 30, 2025 -122.00 Mn
Jun 30, 2025 -1.30 Bn
Jun 30, 2025 -1.30 Bn
Mar 31, 2025 -552.00 Mn
Mar 31, 2025 -552.00 Mn
Dec 31, 2024 536.00 Mn
Dec 31, 2024 536.00 Mn
Sep 30, 2024 111.00 Mn
Sep 30, 2024 111.00 Mn
Jun 30, 2024 -1.17 Bn
Jun 30, 2024 -1.17 Bn
Mar 31, 2024 -208.00 Mn
Mar 31, 2024 -208.00 Mn
Dec 31, 2023 -698.00 Mn
Dec 31, 2023 -698.00 Mn